Crossmark

Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters

Crossref DOI link: https://doi.org/10.1007/s10067-024-06931-6

Published Online: 2024-03-16

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Fangyi

Chen, Qilin

Qi, Xin

Cong, Menglin

Dai, Xinyue

Liu, Huaxiang

Li, Yunfeng https://orcid.org/0000-0002-5743-7508
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No.82002844)

Natural Science Foundation of Shandong Province of China (No. ZR2020QH120)

Natural Science Foundation of Shandong Province of China (No. ZR2021QH007)
License Information

Text and Data Mining valid from 2024-03-16

Version of Record valid from 2024-03-16
More Information

Article History

Received: 15 October 2022

Revised: 2 February 2024

Accepted: 22 February 2024

First Online: 16 March 2024

Compliance with ethical standards

:

: None.

Document is current

Any future updates will be listed below